Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for treating vitreous opacity

A vitreous opacity and composition technology, which is applied in the directions of drug combination, pharmaceutical formula, plant raw materials, etc., can solve the problems of insignificant drug efficacy, the cost of vitrectomy surgery, the unstable efficacy, and the unsatisfactory treatment effect.

Inactive Publication Date: 2017-04-26
JINAN HAOYU QINGTIAN PHARMA TECH CO LTD
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the effect of drugs is not significant, and the cost and curative effect of vitrectomy are also unstable. Therefore, the effect of traditional vitreous opacity treatment is not very satisfactory.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition for treating vitreous opacity

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0035] Embodiment 1: the pharmaceutical composition and preparation method thereof for the treatment of vitreous opacity

[0036] The composition and parts by weight of the raw material drug of the pharmaceutical composition for treating vitreous opacity are: 140g of yellow alum, 90g of β-hedera saponin, 25g of β-hedera saponin, 70g of a stick of incense, and 50g of barley;

[0037] Preparation:

[0038] (1) According to the ratio of the raw materials, take the yellow vitriol, the fern, β-hedera saponin, a stick of incense, and tree head vegetable, mix them evenly, use ethanol with a concentration of 16.5% by weight as a solvent, and soak at 40.5°C Extraction, the number of times of extraction is 14 times, each extraction time is 0.6 hours, each solvent consumption is 33 times of the total weight of the raw material drug, filtered to obtain medicinal residue A and extract A, extract A reclaims ethanol, concentrates to relative Density 1.06, filter, the drug solution passes th...

Embodiment 2

[0041] Embodiment 2: the pharmaceutical composition and preparation method thereof for the treatment of vitreous opacity

[0042] The composition and parts by weight of the raw material drug of the pharmaceutical composition for treating vitreous opacity are: 160g of yellow alum, 80g of β-hedera saponin, 30g of β-hedera saponin, 60g of jacaranda, and 70g of barley;

[0043] Preparation:

[0044] (1) According to the ratio of the raw materials, take the yellow vitriol, the fern, β-hedera saponin, a stick of incense, and tree head vegetable, mix them evenly, use ethanol with a concentration of 16.5% by weight as a solvent, and soak at 40.5°C Extraction, the number of times of extraction is 14 times, each extraction time is 0.6 hours, each solvent consumption is 33 times of the total weight of the raw material drug, filtered to obtain medicinal residue A and extract A, extract A reclaims ethanol, concentrates to relative Density 1.06, filter, the drug solution passes through the...

Embodiment 3

[0047] Embodiment 3: the pharmaceutical composition and preparation method thereof for the treatment of vitreous opacity

[0048] The composition and parts by weight of the crude drug of the pharmaceutical composition for treating vitreous opacity are: 120g of yellow alum, 100g of β-hedera saponin, 20g of β-hedera saponin, 80g of fenugreek, and 40g of barley;

[0049] Preparation:

[0050] (1) According to the ratio of the raw materials, take the yellow vitriol, the fern, β-hedera saponin, a stick of incense, and tree head vegetable, mix them evenly, use ethanol with a concentration of 16.5% by weight as a solvent, and soak at 40.5°C Extraction, the number of times of extraction is 14 times, each extraction time is 0.6 hours, each solvent consumption is 33 times of the total weight of the raw material drug, filtered to obtain medicinal residue A and extract A, extract A reclaims ethanol, concentrates to relative Density 1.06, filter, the drug solution passes through the CD180...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a pharmaceutical composition for treating vitreous opacity and a preparation method thereof, and the pharmaceutical composition is prepared from raw material medicines of Fibroferrite, Plagiogyria distinctissima, beta-hederin, common anotis herb and Crateva unilocularis, can be made into various dosage forms according to conventional preparation processes, and has significant effect for treating of vitreous opacity.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicine, and in particular relates to a pharmaceutical composition for treating vitreous opacity and a preparation method thereof. Background technique [0002] Vitreous opacity refers to the opacity of the vitreous body in the form of dust, filaments, flocs, strands, and flakes, and patients can see black shadows of different shapes flying and drifting in front of their eyes. It is not an independent eye disease, but a common manifestation of many eye diseases, so it is often ignored by people. However, as one of the common clinical signs in ophthalmology, patients often feel that their vision has different degrees of hindrance and discomfort. Severe vitreous opacity can lead to blindness. Since the vitreous body itself has neither blood vessels nor nerve tissue, its metabolism is extremely slow, so when the vitreous body becomes cloudy, the curative effect is often not good. Vitre...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/74A61P27/02A61K31/704A61K33/26
CPCA61K36/74A61K31/704A61K33/26A61K36/11A61K36/185A61K2236/333A61K2236/39A61K2236/55
Inventor 不公告发明人
Owner JINAN HAOYU QINGTIAN PHARMA TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com